Torsten Hoffmann

Torsten Hoffmann

Corporate Officer/Principal presso
American Chemical Society
59 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Torsten Hoffmann is a member of the American Chemical Society and the Swiss Chemical Society.
He was the Managing Director & Chief Scientific Officer at Proteros biostructures GmbH.
He was also the Head-Global Roche Postdoc at Roche Holding AG from 1999 to 2015.
In 2017 to 2018, he was the Chief Operating Officer at Silence Therapeutics Plc.
He was an Associate at The Scripps Research Institute and the Chief Scientific Officer at Oryzon Genomics SA. He was also the Chief Scientific Officer & Executive VP at Zealand Pharma A from 2013 to 2015.
Dr. Hoffmann holds a doctorate degree from the Swiss Federal Institute of Technology.
Currently, he holds positions as a member of the American Chemical Society and the Swiss Chemical Society.

Posizioni attive di Torsten Hoffmann

SocietàPosizioneInizio
Corporate Officer/Principal -
Corporate Officer/Principal -

Precedenti posizioni note di Torsten Hoffmann

SocietàPosizioneFine
SILENCE THERAPEUTICS PLC Direttore operativo 21/06/2018
ZEALAND PHARMA A/S Direttore Tecnico/Scientifico/R&S 01/01/2015
ROCHE HOLDING AG Corporate Officer/Principal 01/01/2015
ORYZON GENOMICS S.A. Direttore Tecnico/Scientifico/R&S -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Torsten Hoffmann

Formazione di Torsten Hoffmann

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

68

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Health Technology

Commercial Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Services

  1. Mercati
  2. Insiders
  3. Torsten Hoffmann